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Abstract: This study was conducted to evaluate the effect of Ecklonia cava, a marine alga 
native to Jeju Island in Korea, on the promotion of hair growth. When vibrissa follicles 
were cultured in the presence of E. cava enzymatic extract (which contains more than 35% 
of dieckol) for 21 days, E. cava enzymatic extract increased hair-fiber length. In addition, 
after topical application of the 0.5% E. cava enzymatic extract onto the back of C57BL/6 
mice,  anagen  progression  of  the  hair-shaft  was  induced.  The  treatment  with  E.  cava 
enzymatic extract resulted in the proliferation of immortalized vibrissa dermal papilla cells 
(DPC). Especially, dieckol, among the isolated compounds from the E. cava enzymatic 
extract, showed activity that increased the proliferation of DPC. When NIH3T3 fibroblasts 
were treated with  the  E. cava  enzymatic  extract  and the isolated  compounds from  the 
E. cava enzymatic extract,  the  E. cava enzymatic extract  increased the proliferation of 
NIH3T3 fibroblasts, but the isolated compounds such as eckol, dieckol, phloroglucinol and 
triphlorethol-A did not affect the proliferation of NIH3T3 fibroblasts. On the other hand, 
the E.  cava  enzymatic  extract  and dieckol  significantly inhibited 5ʱ-reductase  activity. 
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These  results  suggest  that  dieckol  from  E.  cava  can  stimulate  hair  growth  by  the 
proliferation of DPC and/or the inhibition of 5ʱ-reductase activity. 
Keywords: Ecklonia cava; dieckol; hair growth; dermal papilla cells; 5ʱ-reductase activity; 
vibrissa follicle; C57BL/6 mice 
 
1. Introduction 
Androgenetic alopecia (AGA), the most common type of alopecia, is a problem in men over the age 
of 40. Hair loss is a growing trend in the world, however, the prevention of  this condition is not  
simple [1]. Numerous possibilities have been discussed to treat hair loss [2]. Nevertheless, only two 
FDA-approved  drugs  have  been  available  for  AGA  patients,  i.e.,  finasteride  and  minoxidil  [3,4]. 
Finasteride is a type II 5ʱ-reductase inhibitor. It can be used in prostatic hypertrophy [5] as well as in 
hair loss [6]. Minoxidil was used as a drug to treat high blood pressure [7]. However, it was also found 
to promote hair growth [8,9], although the mechanism of minoxidil-induced hair growth is not fully 
understood. In a previous study, minoxidil was shown to have proliferative and anti-apoptotic effects 
on dermal papilla cells [10]. Moreover, it was also found to stimulate hair growth by the opening of  
ATP-sensitive K
+-channel [11,12], the up-regulation of vascular endothelial growth factor (VEGF) [13] 
and the activation of the β-catenin pathway [14] in dermal papilla cells (DPC). The DPC consist of a 
cluster of specialized fibroblasts that play important roles in the regulation of the hair cycle through the 
secretion of diffusible proteins, such as insulin-like growth factor-1 (IGF-1) [15], hepatocyte growth 
factor (HGF) [16], VEGF [13] and transforming growth factor-β (TGF-β) [17,18]. 
Ecklonia cava, a brown alga, grows in the regions of Jeju Island in Korea. In previous reports, 
E. cava has been found to have effects such as anti-bacterial [19] and anti-inflammatory activity [20]. 
E. cava has been reported to contain various phlorotannins—such as eckol, 8,8′-bieckol, 8,4′′-dieckol, 
phlorofucofuroeckol A, triphlorethol-A, phloroglucinol, dioxinodehydroeckol, fucodiphlorethol G [21–24]. 
Eckol  was  reported  to  have  radioprotective  activities  [25],  dieckol  to  have  anti-inflammatory  
effects [26], and triphlorethol-A to have antioxidant activity [22,23]. Recently, it has been found that 
phloroglucinol induced apoptosis [24]. However, the effect and the underlying mechanisms of E. cava 
on hair growth have not been described. In this study, we examined the promotion effects and the 
mechanisms of E. cava extract and its components (eckol, dieckol, triphlorethol-A and phloroglucinol) 
on hair growth. 
2. Results  
2.1. The Effect of Ecklonia cava Enzymatic Extract on the Hair-Fiber Elongation of Rat Vibrissa Follicle 
To determine whether E. cava enzymatic extract could induce hair growth, we examined the effect 
of E. cava enzymatic extract with the use of an organ culture of the rat vibrissa follicle. When the rat 
vibrissa follicles were treated with various concentrations of E. cava enzymatic extract for three weeks, 
in particular, the hair-fiber length with 1 µg/mL of E. cava enzymatic extract treatment showed a Int. J. Mol. Sci. 2012, 13  6409 
 
 
significant increase when compared to the control group (Figure 1). The result indicates that E. cava 
enzymatic extract contains components promoting hair growth. 
Figure 1. Hair growth effect of Ecklonia cava enzymatic extract on rat vibrissa follicles. 
(A,B) Individual vibrissa follicles from Wistar rats were micro dissected and then cultured 
in  William’s  E  medium  at  37  ° C  under  5%  CO2.  Vibrissa  follicles  were  treated  with 
various concentrations of E. cava enzymatic extract and minoxidil sulfate, as indicated. All 
experiments were performed in triplicate. The difference in the length of vibrissa follicles 
of the control group on day 21 was taken to be 100%. Data are presented as the percentage 
of the length of the treated follicles based on the mean length of the control follicles ±  SE.  
* p < 0.05, ** p < 0.01 vs. control. 
 
2.2. The Effect of Ecklonia cava Enzymatic Extract on the Anagen Induction in C57BL/6 Mice 
To investigate whether anagen induction was promoted by  E. cava enzymatic extract, we used 
C57BL/6 mice, since the dorsal hair is known to have a time-synchronized hair growth cycle [27]. 
Shaved  skin  of  telogen  C57BL/6  mice  is  pink,  which  then  darkens  along  with  anagen  initiation.  
As shown in Figure 2, the area of black skin was significantly larger (p < 0.05) in the 0.5% E. cava 
enzymatic extract treated group than in the control group at 26 days after depilation. Induction of the Int. J. Mol. Sci. 2012, 13  6410 
 
 
anagen phase in the 0.5% E. cava enzymatic extract treated group was observed to be faster than in the 
control group. The 5% Minoxidil (MINOXYL
TM) treated group, a positive control group, showed gray 
skin from 13 days after depilation.  
Figure  2.  The  effect  of  Ecklonia  cava  enzymatic  extract  on  the  anagen  induction  in 
C57BL/6 mice. After shaving, the back skins were treated with 0.5% E. cava enzymatic 
extract,  vehicle  and  5%  minoxidil  every  day  for  33  days.  (A)  The  back  skins  were 
photographed  at  1,  7,  13,  20,  26  and  33  days  after  depilation;  (B)  On  day  26,  the 
quantitative  assessment  of  anagen  induction  analyzed  via  dotmatrix  planimetry  was 
performed. The transparency was put on a photo of a mouse to mark the areas that were in 
different stages (pink = telogen, anagen = black). Afterward a dotmatrix (sheet with a 
uniform defined dot pattern) was placed under the marked foil to calculate the percentages 
of the regions of interest by counting the dots. The percentage of anagen induction was 
calculated by the equation [(black skin/total skin) ×  100]. Data are presented as the mean ±  SE 
(n = 6). * p < 0.05, ** p < 0.01, *** p < 0.001 vs. vehicle treated control. 
 
2.3. The Effects of Ecklonia cava Enzymatic Extract and Its Isolated Compounds on the Proliferation 
of Dermal Papilla Cells  
We  examined  the  effects  of  E.  cava  enzymatic  extract  and  its  isolated  compounds  on  the 
proliferation of DPC. When DPC were treated with E. cava enzymatic extract in the concentrations of 
0.001,  0.01,  0.1,  1,  10  and  100  µg/mL,  E.  cava  enzymatic  extract  significantly  promoted  the 
proliferation of DPC compared with the vehicle-treated control at all the concentrations, except the  
100 µg/mL (Figure 3). We evaluated whether the isolated compounds from E. cava enzymatic extract 
such as eckol, dieckol, phloroglucinol and triphlorethol-A, could promote the proliferation of DPC. Int. J. Mol. Sci. 2012, 13  6411 
 
 
DPC were treated with eckol, dieckol, phloroglucinol and triphlorethol-A, individually, at 0.005, 0.01, 
0.05, 0.1, 0.5, 1 and 10 µg/mL for 4 days. The dieckol increased the proliferation of DPC by 100.5%, 
103.9%, 113.5%, 106.1%, 108.1%, 98.5% and 97.3%, respectively (Table 1). The eckol also promoted 
the  proliferation  of  DPC  by  100.8%,  106.1%,  120.3%,  108.5%,  107.8%,  105.4%  and  104.1%, 
respectively (Table 1). However, phloroglucinol and triphlorethol-A did not affect the proliferation of 
DPC (Table 1). 
Figure 3. The effect of Ecklonia cava enzymatic extract on the proliferation of dermal 
papilla cells. Rat vibrissa immortalized DPC (1.0 ×  10
4 cells/mL) were plated in 96 well 
plates. DPC were treated with various concentrations of E. cava enzymatic extract and 
minoxidil sulfate, as indicated. Cell proliferation was measured using a MTT assay for 4 days. 
All  experiments  were  performed  in  triplicate.  Data  are  presented  as  the  mean  ±   SD.  
* p < 0.05, ** p < 0.01, *** p < 0.001 vs. control. 
 
Table 1. The effects of isolated compounds from Ecklonia cava enzymatic extract on the 
proliferation of dermal papilla cells. 
Concentration (μg/mL) 
Compounds 
Eckol  Dieckol  Phloroglucinol  Triphlorethol-A 
0.005  100.8 ±  1.6 *  100.5 ±  4.7 **  102.0 ±  8.5  101.7 ±  7.9 
0.01  106.1 ±  4.5 *  103.9 ±  6.5  100.4 ±  6.8  102.9 ±  3.5 
0.05  120.3 ±  9.9  113.5 ±  6.2 *  96.4 ±  5.3  100.4 ±  8.2 
0.1  108.5 ±  7.7  106.1 ±  5.4  99.6 ±  4.7  99.3 ±  5.2 
0.5  107.8 ±  6.7  108.1 ±  6.2  99.2 ±  4.0  99.4 ±  7.7 
1  105.4 ±  6.2  98.5 ±  6.5  98.3 ±  2.3  103.3 ±  7.5 
10  104.1 ±  9.7  97.8 ±  3.9  76.8 ±  5.6  100.6 ±  4.5 
1 μM Minoxidil sulfate  119.0 ±  8.1 *** 
The proliferation of the control group was regarded as 100% (not shown). All experiments were performed in 
triplicate. Data are presented as the mean ±  SD. *p < 0.05, **p < 0.01, *** p < 0.001 vs. control. 
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2.4. The Effects of Ecklonia cava Enzymatic Extract and Its Isolated Compounds on the Proliferation 
of NIH3T3 Fibroblasts  
Minoxidil, a hair-growth promoting agent, has a mitotic effect on NIH3T3 fibroblasts via KATP 
channel  opening.  Whether  E.  cava  enzymatic  extract,  eckol,  dieckol,  phloroglucinol  and  
triphlorethol-A  could  act  as  an  opener  of  KATP  channel,  proliferation  of  NIH3T3  fibroblasts  was 
examined.  NIH3T3  fibroblasts  were  treated  with  E.  cava  enzymatic  extract,  eckol,  dieckol, 
phloroglucinol and triphlorethol-A at 0.05, 0.1, 0.5, 1 and 10 µg/mL. The E. cava enzymatic extract 
significantly increased the proliferation of NIH3T3 fibroblasts by 119.6%, 118.8%, 116.3%, 113.7% 
and  77.4%,  respectively  (Figure  4A).  To  evaluate  whether  the  E.  cava-induced  proliferation  was 
mediated  through  KATP  channel  opening,  NIH3T3  fibroblasts  were  pretreated  with  tolbutamide,  a  
non-selective  blocker  of  K
+  channels.  Tolbutamide  inhibited  the  E.  cava-induced  proliferation  of 
NIH3T3 fibroblasts (Figure 4B). Nevertheless, it is important to note that dieckol, a major component 
of the E. cava enzymatic extract, did not alter the proliferation of NIH3T3 fibroblasts (data not shown). 
Eckol, phloroglucinol and triphlorethol-A slightly increased the proliferation of NIH3T3 fibroblasts 
compared with the control group (data not shown). 
Figure 4. The effect of Ecklonia cava enzymatic extract on the proliferation of NIH3T3 
fibroblasts. (A,B) Mouse embryonic NIH3T3 fibroblasts (1.0 ×  10
4 cells/mL) were plated 
in 96 well plates. NIH3T3 fibroblasts were treated with various concentration of E. cava 
enzymatic extract, as indicated. Stimulation with minoxidil served as a positive control.  
(B) NIH3T3 fibroblasts were pretreated with tolbutamide for 30 min prior to incubation 
with E. cava enzymatic extract. Cell proliferation was measured using a MTT assay for 
four days. All experiments were performed in triplicate. Data are presented as the mean ±  SD. 
* p < 0.05, ** p < 0.01, *** p < 0.001 vs. control; 
### p < 0.001 vs. E. cava-treated group. 
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2.5. The Effects of Ecklonia cava Enzymatic Extract and Its Isolated Compounds on  
5α-Reductase Activities  
Figure 5. Inhibition effects of Ecklonia cava enzymatic extract and its isolated compounds 
on 5ʱ-reductase activities. (A-E) Assay of 5ʱ-reductase inhibition was performed using a 
crude  extract  of  rat  prostate.  The  reaction  mixture  contained  [1,2,6,7-
3H]  testosterone, 
prostatic enzyme and E. cava enzymatic extract or its isolated compounds (eckol, dieckol, 
phloroglucinol  and  triphlorethol-A).  The  conversion  rate  of  testosterone  (T)  to 
dihydrotestosterone (DHT) was calculated by the equation [DHT/(T + DHT)]. Inhibition 
activity (%) was expressed as a percentage of reduced conversion rate compared to the 
control.  The  inhibition  activity  of  control  group  was  regarded  as  0%  (not  shown). 
Finasteride was used as a positive control. Data are presented as the mean ±  SD of three 
independent  experiments.  *  p  <  0.05,  **  p  <  0.01,  ***  p  <  0.001  vs.  finasteride;  
# p < 0.05, 
## p < 0.01, 
### p < 0.001 vs. control. 
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5ʱ-reductase activity is known to be important for preventing hair loss. We investigated the effects 
of E. cava enzymatic extract, eckol, dieckol, phloroglucinol and triphlorethol-A on the 5ʱ-reductase 
activity using rat prostatic enzyme. As shown in Figure 5, the E. cava enzymatic extract, eckol and 
dieckol  significantly  inhibited  5ʱ-reductase  activities  in  a  dose-dependent  manner  (Figure  5A–C). 
Especially, when the reaction mixture was incubated with 100 µg/mL of dieckol, its inhibition activity 
was similar to that of the finateride treated group, a positive control group (Figure 5C). However, 
phloroglucinol  did  not  affect  5ʱ-reductase  activities  (Figure  5D).  5ʱ-Reductase  activities  in  the 
triphlorethol-A treated group showed a slight inhibition (Figure 5E). 
3. Discussion 
In this study, the hair growth promoting effect of E. cava enzymatic extract, which contains more 
than 35% of dieckol, was investigated in vitro and in vivo. To the best of our knowledge, this study is 
the first to demonstrate that E. cava enzymatic extract and dieckol, a component of E. cava, have the 
potential to promote hair growth via the proliferation of dermal papilla cells and/or the inhibition of 
5ʱ-reductase activity. 
The hair growth cycles, in hair follicle organ cultures of the rat vibrissa follicles, have been reported 
to  be  synchronized  according  to  their  age  [28]  and  the  isolated  rat  vibrissa  follicles  could  be 
maintained in vitro up to 23 days [29]. Use of the organ culture methods to evaluate hair follicle 
growth is thought to be correlated with in vivo systems because the extent of hair growth can be 
observed as the sum of the function of each cell [30]. We found that the E. cava enzymatic extract 
increased the hair-fiber length of follicles by 12.4% at 1 µg/mL, compared with the vehicle-treated 
control. To evaluate the in vivo effect of E. cava enzymatic extract on the induction of the anagen 
phase,  the  hair  growth  promoting  effect  on  C57BL/6  mouse  was  examined.  The  hair  growth 
stimulating in vitro effect of E. cava enzymatic extract was also observed in vivo using C57BL/6 mice.  Int. J. Mol. Sci. 2012, 13  6415 
 
 
The hair follicle consists of several distinct epithelial cells and DPC [31,32]. Regulation of hair 
growth depends on the balance between proliferation and apoptosis in the DPC [10]. As shown in 
figure 3, E. cava enzymatic extract significantly increased the proliferation of DPC. We also examined 
whether  the  isolated  compounds  of  E.  cava  extracts  such  as  eckol,  dieckol,  phloroglucinol  and 
triphlorethol-A, could increase the proliferation of DPC. We observed that eckol and dieckol increased 
the proliferation of DPC, whereas phloroglucinol and triphlorethol-A did not affect proliferation of 
DPC (Table 1). 
K
+ channel opening is involved in not only mitogenesis [33], but also hair growth [34]. In previous 
studies, minoxidil was able to potentiate the mitogenic effects on NIH3T3 fibroblasts through the KATP 
channel  opening  [35].  As  shown  in  Figure  4,  the  E.  cava  enzymatic  extract  could  promote  the 
proliferation of NIH3T3 fibroblasts, which was inhibited by tobutamide, a non-selective blocker of K
+ 
channels. The result indicates that the E. cava enzymatic extract can promote hair growth via the KATP 
channel opening.  
Inhibition of 5ʱ-reductase activity is important in preventing hair loss in AGA [36,37]. E. cava 
enzymatic extract significantly inhibited 5ʱ-reductase activity in a dose dependent manner. Among  
the  isolated  compounds  from  E.  cava  enzymatic  extract—eckol,  dieckol,  phloroglucinol  and 
triphlorethol-A—dieckol was the most active. The results suggest that E. cava enzymatic extract and 
dieckol could have the potential for the treatment of AGA via the inhibition of 5ʱ-reductase activities. 
Previous studies propose that AGA may be caused by DHT in different ways: The miniaturization of 
dermal  papilla  and  hair  follicles  is  induced  by  DHT,  which  leads  to  transition  from  anagen  to  
catagen [38]. DHT increases the levels of transforming growth factor-β1 (TGF-β1) and TGF-β2 in 
dermal papilla cells, which leads to decreased proliferation of epithelial cells [39,40]. Up-regulation of 
dickkopf related protein-1 (DKK-1) by DHT can cause repression of the growth of epithelial cells in 
hair follicles [41]. In further studies, we need to examine whether that E. cava enzymatic extract and 
dieckol can regulate the levels of TGF-β1/β2 and DKK-1 in dermal papilla cells. The androgen action 
and gene expressions in dermal papilla cells (DPCs) from the human beard are known to be different 
from those in DPCs of the human scalp. In the future, therefore, although the structure of hair follicle 
in the human scalp is very similar to that of hair follicle in rat vibrissa, we need to examine whether 
E. cava extract and dieckol can promote hair growth of the human scalp. 
4. Experimental Section 
4.1. Alga Material  
The brown alga, E. cava, was collected along the coasts of Jeju Island in Korea, between February 
and May 2010 and taxonomically identified by Professor Ki Wan Lee. The samples were washed three 
times in tap water to remove any attached salt, epiphytes, and sand. Then, they were rinsed carefully 
with fresh distilled water, and maintained in a medical refrigerator at −20 °C . The frozen samples were 
then lyophilized and homogenized using a grinder prior to extraction. 
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4.2. Preparation of E. cava Enzymatic Extract  
We followed the methods reported in previous studies for the preparation of E. cava enzymatic 
extract [42]. To briefly state the preparation procedure, fifty grams of E. cava were homogenized with 
water (2 L), and mixed with 500 μL of carbohydrate enzyme (celluclast 1.5L FG, Novozyme Nordisk, 
Bagsvaerd,  Denmark).  E. cava  enzymatic extract  was  adjusted to  be  within the optimum pH and 
temperature range of the carbohydrate enzyme  and enzymatic reactions  were performed for 24 h. 
Following extraction, the extract was boiled for 10 min at 100 °C  to inactivate the enzymes. Then,  
E. cava enzymatic extract was clarified by centrifugation (3000 rpm, for 20 min at 4 °C ) to remove the 
residue. E. cava enzymatic extract was adjusted to pH 7.0. 
4.3. Extraction and Isolation of Phlorotannins from Ecklonia cava  
Eckol,  dieckol,  phloroglucinol  and  triphlorethol-A  were  isolated  from  E.  cava  as  previously 
described [43]. In short, the dried E. cava was extracted three times with 80% aqueous EtOH, and was 
evaporated in a vacuum. The EtOH extract was then partitioned with EtOAc. The EtOAc fraction was 
subjected to silica and LH-20 column chromatography. The active compounds were finally purified by 
reversed-phase HPLC (ThermoFisher Scientific, San Jose, CA, USA), and the purified compounds 
were then confirmed by comparing their LC/MS, 
1H NMR data to those in the existing literature [43]. 
Eckol: LC/MS data (M
+, m/z: 372.0 calcd for C18H12O9). 
1H NMR (400 MHz, DMSO-d6) ʴ 9.54 
(1H, s, OH-9), 9.45 (1H, s, OH-4), 9.21 (2H, s, OH-2,7) 9.16 (2H, s, OH-3′,5′), 6.14 (1H, s, H-3), 5.96 
(1H, d, J = 2.8 Hz, H-8), 5.80 (1H, d, J = 1.7 Hz, H-4′), 5.78 (1H, d, J = 2.8 Hz, H-6), 5.72 (2H,  
J = 1.7 Hz, H-2′,6′). 
Dieckol:  LC/MS  data  (M
+,  m/z:  742.0  calcd  for  C36H22O18). 
1H  NMR  (400  MHz,  DMSO-d6)  
ʴ 9.71(1H, s, OH-9), 9.61 (1H, s, OH-9″), 9.51 (1H, s, OH-4″), 9.46 (1H, s, OH-4), 9.36 (2H, s,  
OH-3″,5″), 9.28 (1H, s, OH-2″), 9.23 (1H, s, OH-2), 9.22 (1H, s, OH-7″), 9.15 (2H, s, OH-3′,5′) 6.17 
(1H, s, H-3″), 6.14 (1H, s, H-3), 6.02 (1H, d, J = 2.7 Hz, H-8), 5.98 (1H, d, J = 2.7 Hz, H-8″), 5.95 (1H, 
s,  H-2′,  6″′),  5.82  (1H,  d,  J  =  2.7  Hz,  H-6),  5.81  (1H,  d,  J  =  2.7  Hz,  H-6″),  5.80  (1H,  t,  
J = 2.0 Hz, H-4′), 5.78 (2H, d, J = 2.0 Hz, H-2′,6′). 
Phloroglucinol: LC/MS data (M
+, m/z: 126 calcd for C6H6O3). 
1H NMR (400 MHz, DMSO-d6) ʴ 
8.97 (3H, s, OH-1,3,5), 5.66 (3H, s, H-2,4,5). 
Triphlorethol-A:  LC/MS  data  (M
+,  m/z:  374.0  calcd  for  C18H14O9). 
1H  NMR  (400  MHz,  
DMSO-d6) ʴ 5.7 (1H, d, J = 2.7, H-3), 6.0 (1H, d, J = 2.9, H-5), 5.8 (1H, S, H-3′), 5.8 (1H, S, H-5′), 
6.0 (1H, d, J = 2.2, H-2″), 5.9 (t, J = 2.2, H-4″), 6.0 (1H, d, J = 2.2, H-6″). 
The purity of eckol, dieckol, phloroglucinol and triphlorethol-A was >95%, according to the peak 
area  of  all  components  absorbed  at  each  specific  wavelength  in  HPLC  analysis.  Their  chemical 
structures are shown in Figure 6, and were freshly dissolved in dimethyl sulfoxide (DMSO) (Sigma, St. 
Louis,  MO,  USA)  for  subsequent  treatment.  Further,  minoxidil  sulfate  and  minoxidil  were  also 
dissolved in DMSO for subsequent treatment. The final concentration of DMSO was adjusted to 0.2% 
(v/v) in the following experiment. Tolbutamide was made up as a 410 mM stock solution in ethanol 
and added to the culture media in a final concentration of 0.25% ethanol. 
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Figure 6. Structures of eckol, dieckol, phloroglucinol and triphlorethol-A. 
 
4.4. Animals 
Male Wistar rats (3 weeks of age) were supplied from Orient Bio (Seongnam, Gyeonggi, Korea). 
Six-week-old female C57BL/6 mice and 8-week-old male spargue-Dawley (SD) rats were purchased 
from Dae-Han Biolink (Eumsung, Chungbuk, Korea) and were provided with a standard laboratory 
diet and water ad libitum. All animals were cared for by using protocols (20100031) approved by the 
Institutional Animal Care and Use Committee (IACUC) of the Jeju National University. 
4.5. Isolation and Culture of Rat Vibrissa Follicles  
Isolation of rat vibrissa follicles was performed as described previously [29]. Briefly, rat vibrissa 
follicles were harvested from male Wistar rats that were 23 days old. To accomplish this, the rats were 
sacrificed under carbon dioxide (CO2). Next, both the left and right mystacial pads were removed from 
the rats and placed in a 1:1 (v/v) solution between Earle’s balanced salts solution (EBSS, Sigma,  
St.  Louis,  MO,  USA)  and  PBS  that  contained  100  unit/mL  of  penicillin  and  100  µg/mL  of 
streptomycin.  Anagen  vibrissa  follicles  were  then  carefully  dissected  under  a  stereomicroscope 
(Olympus, Tokyo, Japan) from posterior parts of the mystacial pads, with considerable caution to 
remove the surrounding connective tissue without damaging the vibrissa follicle. Using this method, 
we were able to routinely isolate more than 40 follicles from each animal. The isolated follicles were 
then  placed  in  separate  wells  in  24-well  plates  that  contained  500  µL  of  Williams  medium  E  
(GIBCO Inc, Grand Island, NY, USA) supplemented with 2 mM L-glutamine (Gibco Inc, Grand Island, 
NY, USA), 10 µg/mL insulin (Sigma, St. Louis, MO, USA), 50 nM hydrocortisone (Sigma, St. Louis, 
MO, USA), 100 unit/mL penicillin and 100 µg/mL streptomycin at 37 °C . They were cultivated in an 
atmosphere comprised of 5% CO2 and 95% air. The isolated follicles were then treated with vehicle 
(DMSO diluted 1:1000 in Williams medium E) as a control and E. cava enzymatic extract (0.01, 0.1, 1 
and 10 µg/mL). Minoxidil sulfate (Sigma, St. Louis, MO, USA) was used as a positive control in the Int. J. Mol. Sci. 2012, 13  6418 
 
 
culture systems (Buhl et al., 1990). The culture medium was changed every 3 days and photographs of 
the cultured vibrissa follicles were taken using a stereomicroscope, for 3 weeks. The length of the hair 
follicles was measured using a DP controller (Olympus, Tokyo, Japan). 
4.6. Hair Growth Activity in Vivo  
Anagen was induced on the back skin of C57BL/6 mice that were in the telogen phase of the cycle 
by depilation, as described previously [27]. Briefly, 6-week-old female C57BL/6 mice were allowed to 
adapt to their new environment for one week. The anagen was then induced in the back skin of the  
7-week-old female C57BL/6 mice by shaving, which led to synchronized development of anagen hair 
follicles. From the following day (day 1), 0.2 mL of 0.5% E. cava enzymatic extract in 50% ethanol 
was topically applied every day for 33 days. 5% Minoxidil (MINOXYL
TM; Hyundai Pharm. Co. Ltd., 
Cheonan, Chungnam, Korea) was used as a positive control. The back skin of the mice was then 
observed  and  photographed  at  1,  7,  13,  20,  26  and  33  days  after  shaving.  For  the  quantitative 
assessment, dotmatrix planimetry was performed [44]. 
4.7. Culture and Proliferation Assay of Dermal Papilla Cells  
Rat vibrissa immortalized dermal papilla cell line [45]
 was donated by the Skin Research Institute, 
Amore  Pacific  Corporation  R  &  D  Center,  South  Korea.  The  DPC  were  cultured  in  DMEM  
(Hyclone Inc., Logan, UT, USA), supplemented with 10% fetal bovine serum (Gibco BRL, Grand 
Island, NY, USA) and penicillin/streptomycin (100 unit/mL and 100 µg/mL, respectively), at 37 ° C in 
a humidified atmosphere under 5% CO2. 
The  proliferation  of  DPC  was  evaluated  by  measuring  the  metabolic  activity  using  a  
3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium  bromide  (MTT)  [46].  Briefly,  DPC  at  
1.0× 10
4 cells/mL were seeded into 96-well plate, then cultured for 24 h in a serum-free DMEM, and 
then treated with vehicle (DMSO diluted 1:1000 in serum-free DMEM) as a control, E. cava extract 
(0.001~100  µg/mL),  eckol  (0.005~10  µg/mL),  dieckol  (0.005~10  µg/mL),  phloroglucinol  
(0.005~10 µg/mL), triphlorethol-A (0.005~10 µg/mL) and minoxidil sulfate (1 µM), for 4 days. After 
incubation, 0.1 mg (50 µL of a 2 mg/mL solution) of MTT (Sigma, St. Louis, MO, USA) was added to 
each well, and the cells were then incubated at 37 ° C for 4 h. Next, the plates were centrifuged at 1000 rpm 
for 5 min at room temperature and the media was then carefully aspirated. 200 µL of DMSO was then 
added to each well to dissolve the formazan crystals and the absorbance of the plates, at 540 nm, was 
then read immediately on a microplate reader (BioTek Instrument, Inc., Winooski, VT, USA). All 
experiments were performed three times and the mean absorbance values were calculated. The results 
are  expressed  as  a  percentage  of  absorbance  caused  by  treatment  with  the  extract  or  the  active 
component compared to those of the vehicle treated controls. 
4.8. Culture and Proliferation Assay of NIH3T3 Fibroblasts  
The mouse embryonic NIH3T3 fibroblasts were purchased from ATCC (Rockville, MD, USA) and 
cultured in ATCC-formulated Dulbecco’s Modified Eagle’s Medium (DMEM), supplemented with 10% Int. J. Mol. Sci. 2012, 13  6419 
 
 
(v/v) heat-activated bovine calf serum (BCS), 100 unit/mL penicillin and 100 µg/mL streptomycin at 
37 °C  atmosphere and 5% CO2. 
The proliferation of NIH3T3 fibroblasts was also evaluated by measuring the metabolic activity 
using MTT assay [46]. NIH3T3 fibroblasts, at 1.0 ×  10
4 cells/mL, were seeded into a 96-well plate. 
Cells were incubated for 24 h with DMEM supplemented with 10% BCS, then washed with phosphate 
buffered  saline  (PBS,  Sigma,  St.  Louis,  MO,  USA).  The  cells  were  maintained  with  DMEM 
supplemented with 10% BCS or 1.5% BCS and treated with vehicle (DMSO) as a control, E. cava 
extract  (0.05~10  µg/mL),  eckol  (0.05~10  µg/mL),  dieckol  (0.05~10  µg/mL),  phloroglucinol  
(0.05~10 µg/mL), triphlorethol-A (0.05~10 µg/mL) and minoxidil (75 µM), for 4 days. To clarify 
whether proliferation of NIH3T3 fibroblasts is regulated by KATP channel opening, NIH3T3 fibroblasts 
were pretreated with tolbutamide (2 mM), a non-selective blocker of K
+ channel, for 30 min prior to 
incubation with E. cava enzymatic extract for 4 days. All experiments were performed three times and 
the  mean  absorbance  values  were  calculated.  The  results  are  expressed  as  the  percentage  in  the 
absorbance caused by treatment with the extract or the active component compared to those of the 
vehicle untreated controls. 
4.9. Assay of Rat Prostatic 5α-Reductase  
Male SD rats (8 weeks) were sacrificed with carbon dioxide (CO2). The prostates of rats were 
dissected, freed of their capsules, then washed with saline, and stored at −80 °C . Frozen tissues were 
thawed on ice and procedures were carried out at 4 °C . The tissues were homogenized with Polytron 
homogenizer  (Brinkman  Instruments,  Wesrbury,  NY,  USA)  in  5–6  tissue  volumes  of  medium  A  
(0.32 M sucrose, 1 mM dithiothreitol (DTT), 0.2 mM phenylmethylsulfonylfluoride (PMSF), and 20 mM 
potassium phosphate buffer pH 6.6). The homogenates were centrifuged at  100,000 g for 60 min.  
The pellets  were  recovered, washed  with  three  tissue volumes  of medium  A and centrifuged two 
additional times at 400 g at 0 °C  for 10 min. The washed pellets were suspended in medium A and 
stored at −80 °C  until use. The suspension (2.5 mg protein/mL for Rat prostates, determined by the 
Bradford method) was used as source of 5ʱ-reductase. 
5ʱ-reductase activities were assayed as previously described [47]. The reaction mixture contained a 
final volume of 500 µL: one millimole DTT, 40 mM potassium phosphate buffers, 2 mM NADPH, 
Testosterone including 120 n Ci [1,2,6,7-
3H]. The reaction in triplicate was started when it was added 
to the rat prostatic enzyme fraction (250 µg protein), 0.2% DMSO as a control, E. cava extract (10, 30, 
50,  70  and  100  µg/mL),  eckol  (10,  70  and  100  µg/mL),  dieckol  (10,  70  and  100  µg/mL), 
phloroglucinol (10, 70 and 100 µg/mL) and triphlorethol-A (10, 70 and 100 µg/mL). Finasteride 2 nM 
(MERCK SHARP & DOHME, South Granville, Australia) was used as a positive control. The mixture 
was incubated at 37 °C  for 60 min, and then stopped by adding 1 mL of ethyl acetate and mixing for  
1 min. After centrifugation at 1000 g for 5 min, the organic phase was removed which then was dried 
under a heating plate, dissolved in 50 µL of ethyl acetate containing 500 µg/mL testosterone and  
500  µg/mL  dihydrotestosterone  (DHT)  and  applied  to  a  silica  gel  60  F254  TLC  plate  (Merck, 
Darmstadt,  Germany).  The  plate  was  developed  in  a  solvent  system  consisting  of  an  ethyl 
acetate:cyclohexane (1:1) solution, the plate then was air dried. Testosterone was visibly seen under 
the UV light (254 nm) and DHT was detected using 10% H2SO4 solution via posteriorly heating the Int. J. Mol. Sci. 2012, 13  6420 
 
 
plate. Under these conditions, DHT will be shown as a dark yellow color. Areas containing androgen 
were removed and the strips were soaked in the 5 mL of ULTIMA GOLD
TM Cocktails (PerkinElmer, 
Inc., Waltham, MA, USA) and the radioactivity level was then measured via a liquid scintillation 
counter (Packard Bioscience, Meriden, CT, USA). The activity of 5ʱ-reductase was expressed as the 
ratio [DHT/(T + DHT)] ×  100. 
4.10. Statistical Analyses  
Each  experiment  was  performed  at  least  in  triplicate.  Results  are  expressed  as  mean  ±   SD  or  
mean ±  SE from three separate experiments. The Student’s t test and one-way ANOVA test were used 
to determine the statistical significance.  
5. Conclusions  
In  conclusion,  this  study  demonstrated  that  dieckol,  a  principal  component  of  E.  cava,  could 
stimulate  hair  growth  through  the  proliferation  of  dermal  papilla  cells  and  the  inhibition  of  
5ʱ-reductase activity. These finding indicate that dieckol from E. cava enzymatic extract is a possible 
therapeutic compound for treatment of hair loss. 
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